Hantavirus: A Mild Fever That Can Rapidly Turn Fatal
The recent hantavirus outbreak on the MV Hondius cruise ship has alarmed global health authorities. The World Health Organization (WHO) has reported multiple cases, including deaths, and highlighted the deceptive nature of this rodent-borne virus. Dr. Pradeep Bajad, Senior Consultant in Pulmonary Medicine and Sleep Medicine at Amrita Hospital, Faridabad, explains how a seemingly harmless fever can escalate into a life-threatening lung emergency.
Understanding Hantavirus Transmission
Unlike influenza or COVID-19, hantavirus does not spread easily between people. Instead, infection occurs when individuals inhale microscopic particles contaminated by rodent urine, droppings, or saliva. Enclosed spaces such as cruise ships, warehouses, and poorly ventilated areas pose a high risk. Dr. Bajad notes that the danger can accumulate silently in such environments.
Early Symptoms: The Silent Phase
The illness typically begins with low-grade fever, muscle aches, fatigue, and sometimes nausea. These symptoms resemble a common viral infection, leading many patients and clinicians to underestimate the severity. Dr. Bajad warns that this so-called silent phase is misleading, as the virus can rapidly progress.
WHO Report on MV Hondius Cases
According to WHO, an adult male developed fever, headache, and mild diarrhea on April 6, 2026, while aboard the ship. By April 11, he experienced respiratory distress and died. A female close contact went ashore with gastrointestinal symptoms on April 24, deteriorated during a flight to Johannesburg, and died upon arrival at the emergency department on April 26. Another male patient presented with febrile illness, shortness of breath, and pneumonia on April 24; his condition worsened, and he was evacuated to South Africa, where he remains in ICU. As of May 4, 2026, seven cases—two confirmed and five suspected—have been identified, including three deaths, one critically ill patient, and three with mild symptoms.
The Critical Turning Point
Within days, the infection can change course dramatically. The virus attacks the lungs, causing Hantavirus Pulmonary Syndrome (HPS). Fluid leaks into lung tissue, severely impairing oxygen exchange. Patients rapidly become short of breath, oxygen levels fall, and acute respiratory distress may require ventilatory support. Dr. Bajad emphasizes that timing is crucial: by the time respiratory symptoms are obvious, early intervention opportunities may be lost.
Mortality Rates and Challenges
Clinical studies show that once HPS develops, mortality rates range from 30 to 40 percent, primarily due to delayed recognition and rapid deterioration. Dr. Bajad stresses the importance of early warning signs such as unexplained fatigue, subtle breathlessness, or disturbed sleep due to falling oxygen levels, especially in high-risk settings like ships or warehouses.
Historical Context
Hantavirus was first identified in the 1950s during the Korean War, causing kidney failure and bleeding in American soldiers. The pulmonary form was recognized during a 1990s outbreak in the U.S. Southwest. Global warming, urbanization, and changing rodent populations are making exposure more common worldwide. The cruise ship incident serves as a reminder that not all respiratory threats announce themselves loudly; some begin quietly until the lungs start to fail.
